OIS
REGN icon

Okabena Investment Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Okabena Investment Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-23
Closed -$16.5K – 146
2023
Q2 		$16.5K Buy
23
+20
+667% +$15.4K 0.01% 105
2023
Q1 		$2.46K Sell
3
-2,160
-100% -$1.63M ﹤0.01% 160
2022
Q4 		$450K Buy
+2,163
New +$1.6M 0.3% 68

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Okabena Investment Services's REGN Position: Q3 2023 in Review

Okabena Investment Services sold out of Regeneron Pharmaceuticals (REGN) in Q3 2023, closing a stake of 23 shares — an estimated $16.5K sold.

Okabena Investment Services first reported a position in REGN in Q4 2022 and held it in 3 quarters. The position peaked at $450K in Q4 2022. 1,178 funds tracked by Wall St. Rank hold REGN as of Q3 2023.

  • Okabena Investment Services reported no remaining Regeneron Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Okabena Investment Services sold 23 Regeneron Pharmaceuticals shares in Q3 2023, an estimated $16.5K.
  • Okabena Investment Services first reported a position in Regeneron Pharmaceuticals in Q4 2022 and held it in 3 quarters.
  • Okabena Investment Services's Regeneron Pharmaceuticals position peaked at $450K in Q4 2022.
  • 1,178 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2023.

Based on Okabena Investment Services's 13F filing for Q3 2023, filed 14 Nov 2023.